Oncology

Our leadership in oncology is rooted in heart, science and ingenuity, and driven by a palpable commitment to improve and transform the lives of patients facing a cancer diagnosis. We won’t stop until we get to cure.

— Mathai Mammen, M.D., Ph.D., Global Head, Janssen R&D

I am inspired by our scientists who bring a relentless, innovative focus every day toward our vision of the elimination of cancer, and by the patients who are counting on us to get there.

— Peter Lebowitz, M.D., Ph.D., Global Therapeutic Area Head, Oncology, Janssen R&D

I will continue to help the world beat nicotine addiction and free people from cigarette smoking, the leading cause of preventable disease, including lung cancer.

— Caroline Tillett, Ph.D., Global Head of R&D, Consumer Health, Johnson & Johnson

I collaborate with the best scientists outside our walls to accelerate breakthrough innovations that have the potential to prevent, treat, and even cure cancer.

— Nerida Scott, Head of Johnson & Johnson Innovation, EMEA

I am committed to driving convergent R&D with our talented teams across Johnson & Johnson to help prevent, intercept and cure lung cancer with an aim of transforming the trajectory of this disease for millions of people.

— Avi Spira, M.D., MSc, Global Head, Lung Cancer Initiative, Johnson & Johnson

I challenge our scientists and engineers across all Medical Devices R&D to work together and partner with our Janssen R&D colleagues to build innovative devices and solutions that detect, treat, and ultimately eradicate cancer.

— Peter Shen, Global Head of R&D, Johnson & Johnson Medical Devices

The pandemic shows the importance of being able to prevent, intercept or cure diseases, to eliminate them rather than manage their consequences. At Johnson & Johnson, we are applying these principles to other diseases, including lung cancer. I look forward to a day when people know cancer from history books only.

— Bill Hait, M.D., Ph.D., , Global Head, Johnson & Johnson, External Innovation